BDBM410090 N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-((5-(2-methylthiazol-5-yl)pyridin-2-yl)methyl)chroman-7-yl)benzamide::US10370368, Example 7

SMILES Cc1ncc(s1)-c1ccc(C[C@H]2COc3cc(ccc3[C@@H]2O)-c2ccccc2C(=O)NS(=O)(=O)C(C)(C)C)nc1

InChI Key InChIKey=YKQXBNJAWNFZHS-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 410090   

TargetLeukotriene B4 receptor 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM410090(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  5nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2020
Entry Details
US Patent